Fiseha Temesgen, Tamir Zemenu, Seid Abdurahaman, Demsiss Wondmagegn
Department of Clinical Laboratory Science, College of Medicine & Health Sciences, Wollo University, Dessie, Ethiopia.
BMC Hematol. 2017 Jan 17;17:1. doi: 10.1186/s12878-017-0071-2. eCollection 2017.
Anemia is a strong predictor of mortality and poor quality of life among persons with either renal impairment or HIV infection. In this study, we investigated the prevalence of anemia and its association with renal insufficiency among HIV infected patients initiating ART at a hospital in Northeast Ethiopia.
In this retrospective cohort study, records of 373 patients on ART were selected in Dessie Referral hospital, South Wollo, Northeast Ethiopia from September 2010 to August 2013. Socio-demographic and clinical characteristics of the study patients were collected using standardized data extraction instrument. The abbreviated 4-variable Modification of Diet in Renal Disease (MDRD) study equation was used to estimate renal function (GFR) from serum creatinine. SPSS version 20.0 statistical software was used for data analysis.
The prevalence of anemia at the time of ART initiation was 34.4%; with 20.5, 12.3 and 1.6% mild, moderate and severe anemia, respectively. Renal insufficiency was present in 27.9% of patients and was associated with a high prevalence of anemia (74%). The prevalence of anemia increased with stage of insufficiency, from 23.7% in stage 1 to 100% in stage 4. Impaired renal function (eGFR < 60 mL/min/1.73 m) was associated with a higher risk of all forms of anemia; i.e., mild (AOR = 3.96; 95% CI: 2.76-5.69), moderate (AOR = 2.21; 95% CI: 1.16-4.19) and severe anemia (AOR = 5.89; 95% CI: 1.02-12.03).
HIV infected patients with renal insufficiency had a higher prevalence of anemia compared to patients with normal renal function. Thus, screening of these patients for anemia and renal insufficiency at base line should be critical not only to reduce mortality but also to improve clinical outcomes.
贫血是肾功能损害或感染艾滋病毒者死亡率和生活质量低下的有力预测指标。在本研究中,我们调查了埃塞俄比亚东北部一家医院开始接受抗逆转录病毒治疗(ART)的艾滋病毒感染患者中贫血的患病率及其与肾功能不全的关联。
在这项回顾性队列研究中,从2010年9月至2013年8月在埃塞俄比亚东北部南沃洛的德西转诊医院选取了373例接受抗逆转录病毒治疗患者的记录。使用标准化数据提取工具收集研究患者的社会人口统计学和临床特征。采用简化的4变量肾脏疾病饮食改良(MDRD)研究方程,根据血清肌酐估算肾功能(肾小球滤过率)。使用SPSS 20.0统计软件进行数据分析。
开始接受抗逆转录病毒治疗时贫血的患病率为34.4%;轻度、中度和重度贫血分别为20.5%、12.3%和1.6%。27.9%的患者存在肾功能不全,且与贫血的高患病率相关(74%)。贫血患病率随肾功能不全阶段的增加而升高,从1期的23.7%增至4期的100%。肾功能受损(估算肾小球滤过率<60 mL/min/1.73 m²)与所有形式贫血的较高风险相关;即轻度贫血(调整后比值比[AOR]=3.96;95%置信区间[CI]:2.76 - 5.69)、中度贫血(AOR = 2.21;95% CI:1.16 - 4.19)和重度贫血(AOR = 5.89;95% CI:1.02 - 12.03)。
与肾功能正常的患者相比,肾功能不全的艾滋病毒感染患者贫血患病率更高。因此,在基线时对这些患者进行贫血和肾功能不全筛查不仅对于降低死亡率至关重要,而且对于改善临床结局也很关键。